About us

Hello and welcome to the Cochrane Gynaecological, Neuro-oncology and Orphan Cancers

A new chapter for Cochrane

Cochrane has embarked on an important change programme to transform the way we produce high-quality, independent and timely evidence. The new model is designed to ensure Cochrane remains viable, sustainable, and focused on the greatest global health and care challenges now and into the future.

As part of the new model we are implementing a Central Editorial Service to streamline the editorial process. At the same time, from March 2023, Cochrane Review Groups in the UK will no longer receive NIHR funding. If you are an author currently writing a protocol, review, or update, we are working to ensure a smooth transition with minimal impact on your work.

We are very grateful to everyone who has contributed to Cochrane Gynaecological, Neuro-oncology and Orphan Cancers and very much hope that you will continue to give your time and expertise to Cochrane. We encourage you to look out for further communications about Cochrane's plans for the future and new opportunities to get involved. You can stay connected by:

                   Following Cochrane on your favourite social media platform

                      Opting in to Cochrane email communications in your Cochrane Account

Cochrane invites prospective authors to propose new Cochrane Reviews by submitting a proposal in Editorial Manager. Please see the Cochrane Library information for authors for further details.

At present the CGNOC editorial office is based in Bath, UK. CGNOC is funded by the National Institute of Health Research (NIHR) in the United Kingdom as part of the Research and Development programme. Cochrane is for anyone interested in using high-quality information to make health decisions. Whether you are a doctor or nurse, patient or carer, researcher or funder, Cochrane evidence provides a powerful tool to enhance your healthcare knowledge and decision making.  CGNOC is part of  the Cancer network.

Cochrane’s 11,000 members and over 35,000 supporters come from more than 130 countries, worldwide. Our volunteers and contributors are researchers, health professionals, patients, carers, and people passionate about improving health outcomes for everyone, everywhere. Our global independent network gathers and summarizes the best evidence from research to help you make informed choices about treatment and we have been doing this for 25 years. We respond to the challenge of making the vast amounts of best available evidence generated through research useful for informing decisions about health. Our work is recognised as representing an international gold standard for high quality, trusted information.

We do not accept commercial or conflicted funding. This is vital for us to generate authoritative and reliable information, working freely, unconstrained by commercial and financial interests.

CGNOC are committed to providing reliable evidence required to make important decisions on issues concerning Gynaecological cancers, Neuro-oncology and related topics.

CGNOC's main task is to facilitate the identification of reports of controlled clinical trials and to carry out systematic reviews which are then published on the Cochrane Library. The reviews are updated as new evidence is identified. This ensures that Cochrane reviews are relevant, useful, usable and used. Our aim at CGNOC is to encourage and assist authors to write systematic reviews in a topic area relevant to our group for publication in the Cochrane Library.

Evidence relating to the care of people with cancer comes from a number of sources and so a multi-faceted approach is taken, including searching electronic databases of clinical trial reports, handsearching printed journals, and scanning of the 'grey' literature i.e. conference proceedings and abstracts. Every effort is made to find unpublished trials to avoid bias.

The CGNOC links with other CGs to share ideas.  We also work with the fields and methods working groups to ensure that its reviews are of the highest quality. CGNOG often has common areas of interest with other Cochrane Groups, notably Pain, Palliative and Supportive Care Group, Gynaecology and Fertility Group and all other Cochrane Groups with cancer in their scope.  Every effort is made to avoid duplication.

We are pleased to offer translations in French, Spanish, Croatian and Portuguese. People who wish to search or browse in their own language can do so on Cochrane Summaries;

French - Français (http://summaries.cochrane.org/fr
provided by the French Cochrane Centre

Spanish - Español (http://summaries.cochrane.org/es)
provided by the Iberoamerican Cochrane Centre

Croatian – Hrvatski (http://summaries.cochrane.org/hr)
provided by the Croatian Cochrane Branch

Portuguese - Português (http://summaries.cochrane.org/pt)
provided by the Brazilian Cochrane Centre


National Institute for Health Research (NIHR) is the largest single funder of the Cochrane Gynaecological, Neuro-oncology and Orphan Cancer group and provides core funding for the Editorial Base